184 related articles for article (PubMed ID: 37828981)
61. Cancer-associated fibroblasts impact the clinical outcome and treatment response in colorectal cancer via immune system modulation: a comprehensive genome-wide analysis.
Chen YF; Yu ZL; Lv MY; Cai ZR; Zou YF; Lan P; Wu XJ; Gao F
Mol Med; 2021 Oct; 27(1):139. PubMed ID: 34717544
[TBL] [Abstract][Full Text] [Related]
62. Role of ferroptosis-related genes in prognostic prediction and tumor immune microenvironment in colorectal carcinoma.
Yang C; Huang S; Cao F; Zheng Y
PeerJ; 2021; 9():e11745. PubMed ID: 34316400
[TBL] [Abstract][Full Text] [Related]
63. Profiling of Tumor Microenvironment Components Identifies Five Stroma-Related Genes with Prognostic Implications in Colorectal Cancer.
Liu JW; Yu F; Tan YF; Huo JP; Liu Z; Wang XJ; Li JM
Cancer Biother Radiopharm; 2022 Dec; 37(10):882-892. PubMed ID: 33085921
[No Abstract] [Full Text] [Related]
64. Identification and validation of immunotherapy for four novel clusters of colorectal cancer based on the tumor microenvironment.
Zheng X; Ma Y; Bai Y; Huang T; Lv X; Deng J; Wang Z; Lian W; Tong Y; Zhang X; Yue M; Zhang Y; Li L; Peng M
Front Immunol; 2022; 13():984480. PubMed ID: 36389763
[TBL] [Abstract][Full Text] [Related]
65. Identification of a novel Immune-Related prognostic model for patients with colorectal cancer based on 3 subtypes.
Yang X; Wei Q
Immunobiology; 2023 Mar; 228(2):152352. PubMed ID: 36827833
[TBL] [Abstract][Full Text] [Related]
66. Identification of a Novel Tumor Inflammation Signature for Risk Stratification, Prognosis Prediction, and Immune Status in Colorectal Cancer.
Li Y; Qiu Z; Wang Q; Li S; Zhang Q; Han J
Biomed Res Int; 2022; 2022():3465391. PubMed ID: 35880031
[TBL] [Abstract][Full Text] [Related]
67. A Four-Cell-Senescence-Regulator-Gene Prognostic Index Verified by Genome-Wide CRISPR Can Depict the Tumor Microenvironment and Guide Clinical Treatment of Bladder Cancer.
Sun JX; Liu CQ; Xu JZ; An Y; Xu MY; Zhong XY; Zeng N; Ma SY; He HD; Zhang ZB; Wang SG; Xia QD
Front Immunol; 2022; 13():908068. PubMed ID: 35898492
[TBL] [Abstract][Full Text] [Related]
68. Integrated Analysis of Expression and Prognostic Values of Acyl-CoA Dehydrogenase short-chain in Colorectal Cancer.
Wu Q; Yan T; Chen Y; Chang J; Jiang Y; Zhu D; Wei Y
Int J Med Sci; 2021; 18(16):3631-3643. PubMed ID: 34790035
[No Abstract] [Full Text] [Related]
69. Multi gene mutation signatures in colorectal cancer patients: predict for the diagnosis, pathological classification, staging and prognosis.
Zhuang Y; Wang H; Jiang D; Li Y; Feng L; Tian C; Pu M; Wang X; Zhang J; Hu Y; Liu P
BMC Cancer; 2021 Apr; 21(1):380. PubMed ID: 33836681
[TBL] [Abstract][Full Text] [Related]
70. Follistatin-Like 3 Correlates With Lymph Node Metastasis and Serves as a Biomarker of Extracellular Matrix Remodeling in Colorectal Cancer.
Yang C; Cao F; Huang S; Zheng Y
Front Immunol; 2021; 12():717505. PubMed ID: 34335633
[TBL] [Abstract][Full Text] [Related]
71. m5C regulator-mediated modification patterns and tumor microenvironment infiltration characterization in colorectal cancer: One step closer to precision medicine.
Chen B; Xi Y; Zhao J; Hong Y; Tian S; Zhai X; Chen Q; Ren X; Fan L; Xie X; Jiang C
Front Immunol; 2022; 13():1049435. PubMed ID: 36532062
[TBL] [Abstract][Full Text] [Related]
72. Stemness Related Genes Revealed by Network Analysis Associated With Tumor Immune Microenvironment and the Clinical Outcome in Lung Adenocarcinoma.
Zeng H; Ji J; Song X; Huang Y; Li H; Huang J; Ma X
Front Genet; 2020; 11():549213. PubMed ID: 33193623
[TBL] [Abstract][Full Text] [Related]
73. Construction of a TTN Mutation-Based Prognostic Model for Evaluating Immune Microenvironment, Cancer Stemness, and Outcomes of Colorectal Cancer Patients.
Zhao L; Fan W; Luo K; Xie S; Wang R; Guan J; Chen Z; Jin S
Stem Cells Int; 2023; 2023():6079957. PubMed ID: 36895786
[TBL] [Abstract][Full Text] [Related]
74. Establishment of three heterogeneous subtypes and a risk model of low-grade gliomas based on cell senescence-related genes.
Chen J; Wu L; Yang H; Zhang X; Xv S; Qian Q
Front Immunol; 2022; 13():982033. PubMed ID: 36052073
[TBL] [Abstract][Full Text] [Related]
75. Comprehensive Analysis of a Cancer-Immunity Cycle-Based Signature for Predicting Prognosis and Immunotherapy Response in Patients With Colorectal Cancer.
Hou Y; Zhang R; Zong J; Wang W; Zhou M; Yan Z; Li T; Gan W; Lv S; Zeng Z; Yang M
Front Immunol; 2022; 13():892512. PubMed ID: 35711437
[TBL] [Abstract][Full Text] [Related]
76. Construction of an N6-methyladenosine lncRNA- and immune cell infiltration-related prognostic model in colorectal cancer.
Yu ZL; Zhu ZM
Protoplasma; 2022 Jul; 259(4):1029-1045. PubMed ID: 34734333
[TBL] [Abstract][Full Text] [Related]
77. Identification of pyroptosis-related subtypes, the development of a prognosis model, and characterization of tumor microenvironment infiltration in colorectal cancer.
Song W; Ren J; Xiang R; Kong C; Fu T
Oncoimmunology; 2021; 10(1):1987636. PubMed ID: 34676149
[TBL] [Abstract][Full Text] [Related]
78. Integrative stemness characteristics associated with prognosis and the immune microenvironment in esophageal cancer.
Yi L; Huang P; Zou X; Guo L; Gu Y; Wen C; Wu G
Pharmacol Res; 2020 Nov; 161():105144. PubMed ID: 32810627
[TBL] [Abstract][Full Text] [Related]
79. A novel Anoikis and immune-related genes marked prognostic signature for colorectal cancer.
Cai Z; Zhou F
Medicine (Baltimore); 2022 Nov; 101(46):e31127. PubMed ID: 36401385
[TBL] [Abstract][Full Text] [Related]
80. CX3CR1 Acts as a Protective Biomarker in the Tumor Microenvironment of Colorectal Cancer.
Yue Y; Zhang Q; Sun Z
Front Immunol; 2021; 12():758040. PubMed ID: 35140706
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
